<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:mp ids='MP_0005048'>Thrombosis</z:mp> is a frequent cause of morbidity and <z:hpo ids='HP_0011420'>death</z:hpo> in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>Whether <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is the cause of increased irreversible organ damage and mortality in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> patients is not well established </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Prospective inception cohort of 202 patients with SLE (American College of Rheumatology criteria) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> was defined according to the Sapporo criteria </plain></SENT>
<SENT sid="4" pm="."><plain>Irreversible damage was measured using the Systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> International Collaborating Clinics-American College of Rheumatology damage index (SDI) at 6 months and 1, 3, 5, 10, 15, 20, and 25 years after the diagnosis of SLE </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:hpo ids='HP_0011420'>deaths</z:hpo> were documented </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: A total of 88% of patients were women </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty-eight patients met criteria for definite APS </plain></SENT>
<SENT sid="8" pm="."><plain>Mean (SD) follow-up was 9.7 (6.0) years </plain></SENT>
<SENT sid="9" pm="."><plain>Nine patients could not be contacted for follow-up </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with APS experienced <z:mp ids='MP_0005048'>thrombosis</z:mp>, most of them in the arterial bed </plain></SENT>
<SENT sid="11" pm="."><plain>Damage was more severe in patients with APS than in those without APS (median SDI score, 2 vs 0 at 5 years; P&lt;.001; 4 vs 1 at 15 years; P&lt;.001) </plain></SENT>
<SENT sid="12" pm="."><plain>Cumulative survival at 15 years was lower in patients with APS than in those without APS (65% vs 90%, P =.03) </plain></SENT>
<SENT sid="13" pm="."><plain>Older age at diagnosis, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo>, and APS were independent predictors of mortality </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> with thrombotic manifestations is a major predictor of irreversible organ damage and <z:hpo ids='HP_0011420'>death</z:hpo> in patients with SLE </plain></SENT>
</text></document>